Semi-Annual Consolidated Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7736495

Concept As at
2017-06-30
2017-01-01 to
2017-06-30
As at
2016-12-31
As at
2016-06-30
2016-01-01 to
2016-06-30
As at
2015-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-314,968,000 JPY
-32,607,000 JPY
Depreciation
7,206,000 JPY
9,947,000 JPY
Impairment losses
17,649,000 JPY
1,624,000 JPY
Interest expenses
3,540,000 JPY
1,504,000 JPY
Foreign exchange losses (gains)
1,438,000 JPY
15,680,000 JPY
Decrease (increase) in trade receivables
48,809,000 JPY
122,003,000 JPY
Decrease (increase) in inventories
6,906,000 JPY
17,498,000 JPY
Increase (decrease) in trade payables
-2,491,000 JPY
-15,260,000 JPY
Other, net
22,201,000 JPY
-39,499,000 JPY
Subtotal
-230,990,000 JPY
-137,705,000 JPY
Interest paid
-3,454,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-222,568,000 JPY
-164,107,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-28,621,000 JPY
-27,248,000 JPY
Proceeds from sale of investment securities
JPY
281,876,000 JPY
Net cash provided by (used in) investing activities
-28,738,000 JPY
254,628,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
400,000,000 JPY
Repayments of long-term borrowings
-71,130,000 JPY
-43,348,000 JPY
Redemption of bonds
-14,014,000 JPY
JPY
Net cash provided by (used in) financing activities
-15,582,000 JPY
625,025,000 JPY
Other, net
-99,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-1,877,000 JPY
-19,748,000 JPY
Net increase (decrease) in cash and cash equivalents
-268,766,000 JPY
695,797,000 JPY
Cash and cash equivalents
1,892,419,000 JPY
2,161,186,000 JPY
2,320,738,000 JPY
1,624,941,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.